Table 3.
Association of CVHI score with common CIMT (μm) in women and men in the combined AWI-Gen sample and by countries
| All countries | Burkina Faso | Ghana | Kenya | South Africa | |
|---|---|---|---|---|---|
| β [95% CI] | β [95% CI] | β [95% CI] | β [95% CI] | β [95% CI] | |
| Combined sample | |||||
| Model 1 | − 7.39 [−8.49, −6.27] | − 6.48 [− 9.80, − 3.16] | − 5.42 [− 8.89, − 1.94] | − 6.79 [− 9.24, − 4.35] | − 8.31 [− 10.1, − 6.52] |
| Model 2 | − 7.15 [− 7.89, − 6.41] | − 6.43 [− 9.76, − 3.09] | − 5.46 [− 8.94, − 1.97] | − 6.66 [− 9.12, − 4.19] | − 7.66 [− 9.47, − 5.85] |
| Model 3 | − 7.22 [− 8.04, − 6.39] | − 6.51 [− 9.83, − 3.19] | − 5.42 [− 8.91, − 1.94] | − 6.57 [− 9.05, − 4.10] | −7.85 [− 9.65, − 6.05] |
| Model 4 | − 7.11 [− 7.74, − 6.48] | − 6.42 [− 9.75, − 3.09] | − 5.51 [− 8.99, − 2.02] | − 6.63 [− 9.10, − 4.16] | − 7.49 [− 9.31, − 5.68] |
| Women | |||||
| Model 1 | − 5.98 [− 7.44, − 4.52] | − 2.05 [− 7.73, 3.62] | − 6.04 [− 10.60, − 1.46] | − 6.81 [− 10.2, − 3.43] | − 6.89 [− 9.69, − 4.10] |
| Model 2 | − 5.85 [− 7.00, − 4.71] | − 2.18 [− 7.98, 3.62] | − 6.59 [− 11.20, − 1.96] | − 7.05 [− 10.50, − 3.64] | − 6.62 [− 9.39, − 3.86] |
| Model 3 | − 4.87 [− 5.69, − 4.05] | − 2.83 [− 8.63, 2.97] | − 6.64 [− 11.30, − 1.96] | − 7.05 [− 10.50, − 3.59] | − 6.65 [− 9.44, − 3.86] |
| Model 4 | − 5.93 [− 7.02, − 4.85] | − 2.29 [− 8.10, 3.53] | − 6.79 [− 11.40, − 2.15] | − 7.16 [− 10.60, − 3.71] | − 6.52 [− 9.34, − 3.69] |
| Men | |||||
| Model 1 | − 7.83 [− 9.79, − 5.86] | − 8.62 [− 12.7, − 4.52] | − 4.69 [− 10.1, 0.66] | − 6.66 [− 10.20, − 3.15] | − 9.36 [− 11.70, − 7.01] |
| Model 2 | − 7.42 [− 9.21, − 5.63] | − 8.25 [− 12.4, − 4.14] | − 4.56 [− 9.91, 0.79] | − 6.51 [− 10.00, − 2.99] | − 8.84 [− 11.20, − 6.44] |
| Model 3 | − 5.68 [− 6.57, − 4.80] | − 8.33 [− 12.4, − 4.22] | − 4.38 [− 9.67, 0.92] | − 6.55 [− 10.10, − 3.02] | − 9.19 [− 11.60, − 6.80] |
| Model 4 | − 7.38 [− 9.11, − 5.66] | − 8.18 [− 12.3, − 4.07] | − 4.47 [− 9.81, 0.87] | − 6.42 [− 9.93, − 2.91] | − 8.71 [− 11.10, − 6.32] |
Effect measured as β-coefficient (change in mean CIMT in μm per unit change in CVHI score); model 1 adjusted for age and sex; model 2 adjusted for age, sex, education status, household SES, and site; model 3 adjusted for self-reported history of stroke, heart attack, congestive heart failure, and chronic kidney disease in addition to model 2; model 4 was adjusted for model 2 plus chronic kidney disease and HIV plus antiretroviral therapy (ART) use; model 1 for women and men were adjusted for only age. CVHI cardiovascular health index, CIMT carotid intima-media thickness